Monitoring of clonal evolution of acute myeloid leukemia identifies the leukemia subtype, clinical outcome and potential new drug targets for post-remission strategies or relapse

1. Onecha, E.
2. Rapado, I.
3. Morales, M.L.
4. Carreño-Tarragona, G.
5. Martinez-Sanchez, P.
6. Gutierrez, X.
7. Pina, J.M.S.
8. Linares, M.
9. Gallardo, M.
10. Martinez-López, J.
11. Ayala, R.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.3324/HAEMATOL.2020.254623 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus